Back to trial detailsIntake questionnaire
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Applying to START Center for Cancer Research · San Antonio, Texas
Answer a few short questions to share with the research team.
0 of 3 answered